⌕
Quest Diagnostics · DGX · NYSE
Tenet 47 · Mixed
Compare
$262.21+1.01%At closeTenet 47 · Mixed
$262.21+2.61 (+1.01%)
At close: Nov 16, 2026, 4:00 PM ET· NYSE · USD
$261.25−0.96 (−0.37%)
After hours: Nov 16, 2026, 7:29 PM ET

Quest Diagnostics (DGX) Institutional Ownership

13F filers reported holding 95.9% of Quest Diagnostics (DGX) shares as of Jun 30, 2026, across 1,119 filers.

Sources Ownership filingsQuarter ended How we compute thisNot investment advice

4 figures withheld by our checks. Each blank figure names its reason.

Held by 13F filers
95.9%
Jun 30, 2026
13F filers
1,119
quarter ended Jun 30, 2026
13F value
$22.3B
105.5M shares

Is the smart money (institutions and insiders) accumulating or distributing? One lagging input, not a buy signal.

13F fund flowQuarter ended Jun 30, 2026. Withheld: many filers have already reported a later quarter, so their changes in this quarter are not on file and the counts of new, added, trimmed and closed positions are not shown. These positions are 140 days old; the 45-day figure often quoted is the SEC filing deadline after quarter-end, not the age of the data. The counts above compare each filer’s position with its own previous 13F. The change in the number of filers and in the ownership share is not shown: the filings we read hold only each filer’s latest 13F, so there is no earlier quarter of the same filers to compare against. That is a limit of the source, not a statement about this company.
Basis: shares reported by 1,119 13F filers for Jun 30, 2026, over shares outstanding implied from the current quote, measured 140 days apart. It measures the ownership we have filings for, not total institutional ownership, and it moves with the share count between filings.
routine sells are usually compensation mechanics; open-market buys are the rarer signal. Rows labelled with another security are the derivative leg of a vest or exercise, not share sales
DateNameRoleTypeSharesPriceSEC filing
Nov 9, 2026Plewman PatrickSVP for Diagnostic ServicesAcquired · Option exercise4,274$127.73↗
Nov 9, 2026Plewman PatrickSVP for Diagnostic ServicesDisposed · Open-market sale4,274$257.34↗
Nov 9, 2026Plewman PatrickSVP for Diagnostic ServicesAcquired · Option exercise6,793$127.81↗
Nov 9, 2026Plewman PatrickSVP for Diagnostic ServicesDisposed · Open-market sale6,793$257.34↗
Nov 9, 2026Plewman PatrickSVP for Diagnostic ServicesDisposed · Open-market sale650$257.34↗
Nov 9, 2026Plewman PatrickSVP for Diagnostic ServicesDisposed · Option exercise4,274Non-Qualifed Stock Option (right to buy)$127.73↗
Nov 9, 2026Plewman PatrickSVP for Diagnostic ServicesDisposed · Option exercise6,793Non-Qualifed Stock Option (right to buy)$127.81↗
Nov 3, 2026Ramachandran SubuSVP, Regional BusinessesAcquired · Grant / award352—↗
Nov 3, 2026Ramachandran SubuSVP, Regional BusinessesAcquired · Grant / award1,386Non-Qualifed Stock Option (right to buy)—↗
Nov 3, 2026Doherty Catherine T.Executive Vice PresidentAcquired · Grant / award4,827—↗
Nov 3, 2026Doherty Catherine T.Executive Vice PresidentAcquired · Option exercise22,105$121.81↗
Nov 3, 2026Doherty Catherine T.Executive Vice PresidentDisposed · Open-market sale3,818$245.45↗
Nov 3, 2026Doherty Catherine T.Executive Vice PresidentDisposed · Open-market sale5,990$246.26↗
Nov 3, 2026Doherty Catherine T.Executive Vice PresidentDisposed · Open-market sale1,151$246.98↗
Nov 3, 2026Doherty Catherine T.Executive Vice PresidentDisposed · Open-market sale2,358$248.38↗
Nov 3, 2026Doherty Catherine T.Executive Vice PresidentDisposed · Open-market sale3,004$249.40↗
Nov 3, 2026Doherty Catherine T.Executive Vice PresidentDisposed · Open-market sale2,877$250.49↗
Nov 3, 2026Doherty Catherine T.Executive Vice PresidentDisposed · Open-market sale2,907$251.24↗
Nov 3, 2026Doherty Catherine T.Executive Vice PresidentDisposed · Option exercise22,105Non-Qualifed Stock Option (right to buy)$121.81↗
Nov 3, 2026DELANEY MARK ESVP & Chief Commercial OfficerAcquired · Grant / award2,615—↗

* Holdings as reported for Jun 30, 2026, 140 days old; funds file up to 45 days after each quarter-end, so the newest complete quarter runs 45 to 135 days behind.

** A price of “—” marks an option exercise, RSU vest or a filing without a usable per-share price, not a $0 trade.

How much of Quest Diagnostics do institutions hold?

13F filers reported holding 95.9% of Quest Diagnostics' shares as of Jun 30, 2026, across 1,119 filers.

How many 13F filers hold Quest Diagnostics?

Quest Diagnostics was held by 1,119 13F filers as of Jun 30, 2026.

Not investment advice.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.